Recursion Pharmaceuticals (RXRX) SEC Filings & 10K Form

$9.42
-0.09 (-0.95%)
(As of 05/17/2024 08:54 PM ET)

Recent Recursion Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/17/2024
6:11 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:11 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:12 PM
Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2024
6:12 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:35 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:46 PM
Recursion Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/03/2024
5:24 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
4:41 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
9:43 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2024
11:49 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/30/2024
3:19 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/29/2024
5:41 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2024
4:16 PM
Recursion Pharmaceuticals (Filer)
Form DEFA14A
04/23/2024
4:29 PM
Recursion Pharmaceuticals (Filer)
Form ARS
04/18/2024
4:12 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/18/2024
4:12 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2024
3:18 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
3:55 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144/A
04/16/2024
3:15 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/16/2024
7:04 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/05/2024
4:44 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
10:13 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/04/2024
9:39 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
4:42 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:42 PM
Burrell Terry-Ann (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:43 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:43 PM
CHAVEZ R. MARTIN (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
4:43 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2024
10:09 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/02/2024
4:01 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
5:40 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
11:43 AM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/25/2024
5:39 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
4:38 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:35 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2024
3:35 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2024
6:28 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
3:48 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2024
3:32 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/08/2024
6:08 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:53 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Urgent Nvidia Warning (Ad)

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…
03/06/2024
4:39 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
3:59 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
7:25 AM
Recursion Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/23/2024
6:22 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2024
5:13 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/21/2024
4:37 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
3:29 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
6:57 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:58 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/16/2024
6:59 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2024
5:00 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
5:55 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:00 PM
Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:01 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:03 PM
Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2024
11:21 AM
ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2024
4:34 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
8:49 AM
FMR LLC (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G
02/08/2024
5:54 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:40 PM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
5:52 PM
Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
4:25 PM
BlackRock Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G/A
01/29/2024
3:00 PM
ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
Form SC 13G
01/25/2024
5:13 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
9:13 AM
Recursion Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
01/23/2024
3:20 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/18/2024
5:37 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/18/2024
5:39 PM
Recursion Pharmaceuticals (Issuer)
Virani Shafique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2024
3:34 PM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/16/2024
8:55 AM
Recursion Pharmaceuticals (Subject)
Virani Shafique (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/11/2024
5:50 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
5:51 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
4:02 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:14 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:15 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/08/2024
6:59 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
7:03 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:11 PM
Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:11 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
5:11 PM
CHAVEZ R. MARTIN (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
3:58 PM
Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
4:48 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:11 PM
Larson Tina Marriott (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:32 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2023
7:01 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2023
6:22 PM
Recursion Pharmaceuticals (Issuer)
Virani Shafique (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2023
5:44 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/15/2023
11:08 AM
Recursion Pharmaceuticals (Subject)
Virani Shafique (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/15/2023
7:38 AM
Recursion Pharmaceuticals (Filer)
Form 424B7
12/15/2023
7:41 AM
Recursion Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Claim Your Complimentary Bitcoin Reward (Ad)

Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Secure Your Spot Now
12/14/2023
5:51 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
5:53 PM
Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
12:58 PM
Dar Zavain (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/13/2023
10:15 AM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
3:24 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
9:46 AM
Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/08/2023
4:22 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2023
1:57 PM
Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/30/2023
4:41 PM
Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:RXRX) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners